Rheumatology Rundown: Birth Control Guidance, Gene Therapy, Gout Treatment
Birth control guidance provided to women taking rheumatoid arthritis therapies is lacking, and other rheumatology news reported across MJH Life Sciences™.
Gene Therapy for SLC13A5 Deficiency Shows Promise in Preclinical Data
No adverse effects on weight, general activity, or survival in knockout mice and wild type littermates were observed throughout the study.
Novel RNA-Targeting Gene Therapy Shows Promise for Neuromuscular, Retinal Diseases
The CEO of Locanabio shares details of 2 presentations the company is making this week at the 24th Annual Meeting of the American Society of Gene & Cell Therapy.
Sickle Cell Disease Gene Therapy on Hold After Adverse Events
Following 2 unexpected serious adverse events, the trial was put on clinical hold as of February 2021.
Intra-Articular FX201 Gene Therapy Shows Promise for Osteoarthritis
The therapy was generally well-tolerated and offered substantial pain relief in patients.
